The Sun Pharma's ordeal with the US drug regulator continues as its Halol Manufacturing facility in Gujarat is already under USFDA scanner facing import alert. Its Mohali unit also swaits USFDA ...
Regulatory troubles continue for Sun Pharma as the drug manufacturer’s ... Analysts at HSBC expect the FDA move to add to the regulatory overhang for the drugmaker, while those at Nomura ...
The FDA said U.S. healthcare workers should avoid all plastic syringes manufactured by Jiangsu Shenli Medical Production as the agency investigates multiple syringe suppliers. In two import alerts ...
Once the rain exits Friday night, it remains breezy through Saturday, but at least the sun comes back out. The next day to watch for potentially impactful weather is Sunday. Much of the day stays ...
Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the inspection ...
Sun Pharmaceutical Industries shares dropped 3.4 percent as the US FDA labelled its Dadra facility ... inspection from December 4 to 15, 2023, Sun Pharma disclosed the classification status ...
Friday, 12 members of an FDA advisory committee voted unanimously ... patients with multiple myeloma,” the company told Fierce Pharma a few days ahead of the Friday meeting.
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Royalty Pharma plc (Symbol: RPRX) entered into oversold territory, hitting an RSI reading of ...
At this price, the company commanded a market capitalisation (m-cap) of Rs 57,038.9 crore. Sun Pharma Advanced Research Company Ltd shares slumped 4.99% to close at Rs 408.25. The company's m-cap ...
A 23-year-old man who was hit by an SUV in Surrey last Friday has died. We apologize, but this video has failed to load. Try refreshing your browser, or tap here to see other videos from our team ...
Increased import costs are part of the problem. The U.S. is the largest goods importer in the world, bringing in $3.2 trillion in 2022. Import costs rose dramatically in 2021 and 2022 due to ...
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...